Biopharmaceutical firm Worg snapped up almost $58 million in a Series B round while medical device maker Vathin and Taiwanese biotech firm HanchorBio also received funding. Separately, KKR has invested in pet hospital chain Ruichen.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
